Tumoroid‐On‐a‐Plate (ToP): Physiologically Relevant Cancer Model Generation and Therapeutic Screening
Open Access
- 13 November 2024
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (1) , e2402060
Abstract
Employing three‐dimensional (3D) in vitro models, including tumor organoids and spheroids, stands pivotal in enhancing cancer therapy. These models bridge the gap between two‐dimensional (2D) cell cultures and complex in vivo environments and offer versatile tools for comprehensive studies into cancer progression, drug responses, and tailored therapies. This study introduces the Tumoroid‐on‐a‐Plate (ToP) device, an innovative ope‐surface microfluidic platform designed to create predictive 3D models of solid tumors. The ToP device combines tumor mass, stromal cells, and extracellular matrix (ECM) components, to closely replicate the microenvironment of glioblastoma (GBM) and pancreatic adenocarcinoma (PDAC). Using the advanced ToP model and testing various GBM ECM compositions such as collagen and Rreelin within the model, we can assess how specific elements affect GBM invasiveness. The ToP in vitro model also enables screening chemotherapeutics such as temozolomide and iron‐chelators in a single and binary treatment setting on the complex ECM‐embedded tumoroids to evaluate their toxicity on GBM and PDAC models viability and apoptosis. Furthermore, co‐culturing PDAC tumoroids with human‐derived fibroblasts reveals the pro‐invasive influence of stromal elements on tumor growth and drug response. This research underscores the value of advanced 3D models like ToP in advancing the understanding of cancer complexity and therapy responses.Keywords
All Related Versions
Funding Information
- Natural Sciences and Engineering Research Council of Canada
- Canada Foundation for Innovation
This publication has 51 references indexed in Scilit:
- Strategies increasing the effectiveness of temozolomide at various levels of anti-GBL therapyBiomedicine & Pharmacotherapy, 2023
- Mimicking Tumor Cell Heterogeneity of Colorectal Cancer in a Patient-derived Organoid-Fibroblast ModelCellular and Molecular Gastroenterology and Hepatology, 2023
- Tumor organoids: Opportunities and challenges to guide precision medicineCancer Cell, 2021
- A Phase I Trial of Oxaliplatin, Irinotecan, and S-1 Combination Therapy (OX-IRIS) as Chemotherapy for Unresectable Pancreatic Cancer (HGCSG 1403)The Oncologist, 2021
- Tumor organoids: From inception to future in cancer researchCancer Letters, 2019
- Contributions of 3D Cell Cultures for Cancer ResearchJournal of Cellular Physiology, 2017
- Astrocyte-induced Reelin expression drives proliferation of Her2+ breast cancer metastasesClinical & Experimental Metastasis, 2017
- A three dimensional micropatterned tumor model for breast cancer cell migration studiesBiomaterials, 2016
- Microwell fabrication methods and applications for cellular studiesBiomedical Engineering Letters, 2013
- Pancreatic cancer–associated stroma productionThe American Journal of Surgery, 2007